CD68 and neoplasm: Within the tumor microenvironment, myeloid cells were predominant, represented by CD11c+ DCs (3.13%, Figures 1A, B) and CD68+ macrophages (0.33%, Figures 1A, B), while T lymphocytes accounted for only 0.16% (Figures 1A, B).